Similar to the family based studies, a contribution of rare CNVs to disease is evident in the overall genome-wide burden of rare variants (i.e., the number of CNVs carried by an individual). An enrichment of large (>100 kb) CNVs in patients as compared with controls has been reported in schizophrenia, autism and bipolar disorder.
